Respiratory Analytics is a UK-based startup pioneering the use of AI, sensor technology, and big data to revolutionize the management of respiratory conditions such as asthma, COPD, and cystic fibrosis. Their flagship product, aflo™, is a 'smart inhaler' designed to assist individuals in correctly administering medication while gathering and analyzing their data alongside air quality and viral information. Supported by funding from Innovate UK, Techstart NI, and CoFund, the company is at the forefront of addressing life-threatening symptoms associated with respiratory ailments. Since its establishment in 2019, Respiratory Analytics operates within the Health Care and Medical Devices sectors, showcasing potential for significant impact and growth.
General Information
BounceWatch is an independent company data service, not affiliated with Respiratory Analytics. To contact Respiratory Analytics, visit afloanalytics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United Kingdom Market
Health Care
About Respiratory Analytics
Taxonomy: respiratory management, technology, asthma, COPD, medical device, remote monitoring, symptom control, innovation
No funding data available for Respiratory Analytics yet.
Respiratory Analytics Alternatives & Competitors
View All AlternativesSmart inhalers that make remote asthma care a reality
Digital Lung Acoustics for Better Insight | Cough, Wheeze, Crackles
VitalFlo's mission is to make respiratory patient management easy, reduce cost of care, and improve...
FAQ About Respiratory Analytics
Source: BounceWatch company record for Respiratory Analytics, https://bouncewatch.com/company/respiratory-analytics, updated 27 December 2024. When citing, please name BounceWatch and link this page.